{"transactions":[{"id":2419290,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":130946,"kind":"person","name":"Attie Kenneth","position":1,"cik":"0001454829","reported_name":"Attie Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-01T23:26:36.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":34100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and the remaining shares vesting in equal quarterly installments thereafter."}],"balance_after":34100,"derivative":{"exercise_price":1.38,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":34100},"source":{"system":"sec-edgar","filing":"0001209191-22-006037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000120919122006037/doc4.xml","form_type":"4"}},{"id":2419289,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":130946,"kind":"person","name":"Attie Kenneth","position":1,"cik":"0001454829","reported_name":"Attie Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO"}}],"security":"Common Stock","published_at":"2022-02-01T23:26:36.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":34100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest over four years, with 25% of the shares vesting in equal annual installments until the fourth anniversary of the grant date."}],"balance_after":34100,"source":{"system":"sec-edgar","filing":"0001209191-22-006037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000120919122006037/doc4.xml","form_type":"4"}},{"id":2892152,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":130946,"kind":"person","name":"Attie Kenneth","position":1,"cik":"0001454829","reported_name":"Attie Kenneth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:14:01.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and the remaining shares vesting in equal quarterly installments thereafter."}],"balance_after":110000,"derivative":{"exercise_price":13.83,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-21-005873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000120919121005873/doc4.xml","form_type":"4"}}]}